0001678852-17-000004.txt : 20171117 0001678852-17-000004.hdr.sgml : 20171117 20171117151008 ACCESSION NUMBER: 0001678852-17-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171117 DATE AS OF CHANGE: 20171117 EFFECTIVENESS DATE: 20171117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Palleon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001678852 IRS NUMBER: 474541546 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-266476 FILM NUMBER: 171210727 BUSINESS ADDRESS: STREET 1: 266 SECOND AVENUE, 2ND FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857 285 5900 MAIL ADDRESS: STREET 1: 266 SECOND AVENUE, 2ND FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Palleon Pharma Inc. DATE OF NAME CHANGE: 20160706 D/A 1 primary_doc.xml X0708 D/A LIVE 0001678852 Palleon Pharmaceuticals Inc. 266 SECOND AVENUE, 2ND FLOOR WALTHAM MA MASSACHUSETTS 02451 857 285 5900 DELAWARE Palleon Pharma Inc. Corporation true 2015 James W. Broderick 266 Second Avenue, 2nd Floor Waltham MA MASSACHUSETTS 02451 Executive Officer Director Jens Eckstein 266 Second Avenue, 2nd Floor Waltham MA MASSACHUSETTS 02451 Director Stephen Hoffman 266 Second Avenue, 2nd Floor Waltham MA MASSACHUSETTS 02451 Director William Burkoth 266 Second Avenue, 2nd Floor Waltham MA MASSACHUSETTS 02451 Director Karen Hong 266 Second Avenue, 2nd Floor Waltham MA MASSACHUSETTS 02451 Director James Lee 266 Second Avenue, 2nd Floor Waltham MA MASSACHUSETTS 02451 Director John Hennessy 266 Second Avenue, 2nd Floor Waltham MA MASSACHUSETTS 02451 Executive Officer Biotechnology Decline to Disclose 06b true 0001678852-16-000001 2016-06-22 true true false 0 48280879 20612790 27668089 false 6 0 0 0 The Issuer will use proceeds of the offering for general working capital purposes which may include payments to its executive officers and other employees in the ordinary course of business. false Palleon Pharmaceuticals Inc. /s/ James W. Broderick James W. Broderick President 2017-11-17